Early Detection Research Award
Funded by LUNGevity Foundation and Partnership for Cures
Jeffrey A. Borgia, PhD
Rush University Medical Center
Chicago
IL
Dr. Borgia is working to develop new biomarkers to strengthen the capabilities of the existing blood test for identifying the presence of metastatic progress in non-small cell lung cancer that he has developed. He plans to adapt the blood test to a diagnostic card format so that high-risk individuals can put blood droplets on diagnostic cards at home and mail them to a test facility where the blood will be extracted and tested for the biomarkers in the panel.